These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3661180)

  • 1. Effect of a modified fluid therapy on renal function during indomethacin therapy for persistent ductus arteriosus.
    Leititis JU; Burghard R; Gordjani N; Wildberg A; Seyberth HW; Brandis M
    Acta Paediatr Scand; 1987 Sep; 76(5):789-94. PubMed ID: 3661180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus.
    Cifuentes RF; Olley PM; Balfe JW; Radde IC; Soldin SJ
    J Pediatr; 1979 Oct; 95(4):583-7. PubMed ID: 480039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of renal prostaglandins for kidney function in early childhood].
    Seyberth HW
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):178-84. PubMed ID: 3600669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus.
    Lin YJ; Tsai YJ; Chen JS; Lin JS; Wu JM; Lin CH; Yeh TF
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):104-7. PubMed ID: 7793274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
    Brion LP; Campbell DE
    Cochrane Database Syst Rev; 2000; 2001(2):CD001148. PubMed ID: 10796253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
    Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
    Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
    Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
    Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal effects of prolonged indomethacin therapy in premature infants].
    Gouyon JB; Chouchane M; Françoise M
    Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
    John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
    Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
    Yeh TF; Achanti B; Patel H; Pildes RS
    Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period.
    Lee BS; Byun SY; Chung ML; Chang JY; Kim HY; Kim EA; Kim KS; Pi SY
    Neonatology; 2010; 98(2):191-9. PubMed ID: 20234144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus.
    Yeh TF; Thalji A; Luken L; Lilien L; Carr I; Pildes RS
    Chest; 1981 Dec; 80(6):698-700. PubMed ID: 7307591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
    Yeh TF; Wilks A; Singh J; Betkerur M; Lilien L; Pildes RS
    J Pediatr; 1982 Sep; 101(3):433-7. PubMed ID: 7108667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?
    Hammerman C; Shchors I; Jacobson S; Schimmel MS; Bromiker R; Kaplan M; Nir A
    Pediatr Res; 2008 Sep; 64(3):291-7. PubMed ID: 18458658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus.
    Seri I; Tulassay T; Kiszel J; Csömör S
    Int J Pediatr Nephrol; 1984 Dec; 5(4):209-14. PubMed ID: 6397454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.